Diabetes management for South Asians in Canada — why standard targets may not be enough

If you're South Asian and living in Canada with a diabetes diagnosis — or a fasting glucose that's creeping up, or a family history that never lets you fully relax — you may have been given the same advice everyone else gets: watch your weight, hit an HbA1c target, come back in three months. That advice isn't wrong. But for South Asians, it can be incomplete. The biology of type 2 diabetes in our community is genuinely different, and applying a one-size-fits-all Canadian playbook can mean risk gets under-detected and under-treated for years. This article explains what's different, why standard targets may not be enough, and exactly what to raise with your GP — for yourself, or for an elderly parent back in India whose reports land in your inbox.

The South Asian diabetes phenotype — why the same weight isn't the same risk

South Asians develop type 2 diabetes at a lower body weight and a younger age than most other populations, and the reason sits in body composition, not willpower. At any given BMI, South Asians tend to carry more visceral (abdominal) fat and less muscle mass — a pattern often called the "thin-fat" phenotype. Visceral fat is metabolically active and drives insulin resistance, so a person who looks slim on a standard BMI chart can already be deeply insulin resistant. It's why you'll meet South Asian patients diagnosed with type 2 diabetes at a BMI of 24 — a number a general-population chart calls "normal."

This isn't a minor statistical quirk. It changes who should be screened, when, and how aggressively. If the trigger for concern is a BMI of 30, a large share of at-risk South Asians never trip the wire until the disease is already established.

Why standard BMI cut-offs under-detect risk

The BMI thresholds baked into most Canadian screening tools were derived largely from European-ancestry populations. For South Asians, expert bodies recommend lower cut-offs: overweight begins at a BMI of ≥23 kg/m² and obesity at ≥27.5 kg/m², rather than the familiar ≥25 and ≥30. Waist circumference thresholds are lower too, because abdominal fat is the part that matters most metabolically.

The practical consequence: a South Asian patient whose BMI reads 24 and whose weight looks unremarkable may be carrying exactly the visceral-fat and insulin-resistance profile that warrants earlier screening and earlier intervention — but a generic tool waves them through. If you've ever been told "your weight is fine, don't worry," it's worth knowing that "fine" was almost certainly measured against the wrong ruler.

Complications hit harder and earlier

It isn't only that diabetes arrives sooner. South Asians also face higher rates of complications — and the complications are the part that actually shortens and worsens lives. Three deserve particular attention:

• Cardiovascular disease. South Asians have a markedly elevated risk of heart disease, frequently at younger ages and lower cholesterol numbers than expected. Part of this is an atherogenic lipid pattern — higher triglycerides, smaller dense LDL particles, and elevated Lp(a), a largely genetic risk factor that standard lipid panels don't measure. Our companion piece on heart disease risk in South Asians in Canada goes deeper here.
• Kidney disease (diabetic nephropathy). Diabetic kidney damage is more common and can progress faster in South Asians. Early kidney injury is silent — you feel nothing — which is why screening the urine (albumin-to-creatinine ratio) and eGFR matters. See our companion article on kidney disease risk in South Asians.
• Retinopathy. Diabetic eye disease, another silent complication, is more prevalent and argues for diligent retinal screening rather than waiting for symptoms.

The through-line is that diabetes management for South Asians is not just about the sugar number. An HbA1c at target does not, on its own, protect the heart, kidneys, or eyes.

Why generic advice may be insufficient — and what modern management looks like

Given the risk profile above, several shifts in emphasis are reasonable to discuss with your care team:

Earlier and broader screening

Lower BMI and waist thresholds, screening at younger ages, and a lower bar for investigating people with a strong family history. Prediabetes is the window where progression can still be prevented — if you're in it, our guide on what to do about prediabetes in Canada is the place to start.

Cardio-renal protection, not just glucose lowering

Two drug classes have transformed diabetes care by protecting the heart and kidneys independently of their glucose-lowering effect: SGLT2 inhibitors and GLP-1 receptor agonists. For a South Asian patient with elevated cardiovascular or kidney risk, these are often exactly the therapies where the biggest gains lie — yet they aren't always front-of-mind in a busy general-practice appointment. It is entirely reasonable to ask whether one of these is appropriate for you.

Lipids beyond the standard panel

Because of the atherogenic lipid pattern and higher Lp(a), it's worth asking about ApoB and a one-time Lp(a) measurement in addition to the usual cholesterol numbers. These give a truer picture of cardiovascular risk than LDL alone.

Culturally appropriate diet

Standard dietary advice often doesn't map onto a South Asian kitchen. Traditional diets can be heavy in white rice and refined carbohydrates, which carry a high glycaemic load and spike blood sugar. The answer usually isn't to abandon the food you grew up with — it's practical adjustment: smaller rice portions, swapping to whole grains and higher-fibre options, pairing carbohydrates with protein and vegetables, and being deliberate about portion size. Advice that ignores the cultural reality of the plate tends to be advice that doesn't get followed.

Remission is genuinely on the table

One of the most hopeful shifts in recent years: type 2 diabetes remission is possible with significant, sustained weight loss, particularly in the earlier years after diagnosis. This deserves a real conversation rather than quiet resignation to lifelong medication. If you were recently diagnosed, our guide for the newly diagnosed with type 2 diabetes in Canada lays out the first steps.

PGIMER and AIIMS — expertise built on this exact phenotype

Here's something that matters and doesn't get said enough: the two institutions with the deepest, most everyday experience managing the South Asian diabetes phenotype aren't in Toronto or Vancouver — they're in India. PGIMER Chandigarh and AIIMS manage this biology at enormous scale, every single day: the thin-fat phenotype, aggressive insulin resistance, early cardio-renal complications, and remission-focused weight loss in South Asian patients specifically. For a Canadian endocrinologist, the South Asian patient is one presentation among many. For these institutions, it is the core of the practice.

Ginie Health exists to connect Canadian patients to exactly that expertise. And it's worth being honest about why the timing matters: with endocrinology waits in much of Canada running four to six months after a GP referral, a written specialist opinion within hours isn't a luxury — for a condition where the most treatable window can close, it's the difference between managed time and lost time.

For NRI families — two health systems, one family

There's a scenario I hear constantly from the NRI community, because it's my own. You're managing your own diabetes risk in Canada — and at the same time, you're the one your elderly parents in India forward their lab reports and prescriptions to. Suddenly you're trying to make sense of a Canadian HbA1c and an Indian fasting-sugar report, two different medication lists, two different sets of reference ranges, and no single doctor who sees both.

This is precisely the gap Ginie Health is built to close. A specialist can review your Canadian labs to tell you whether your management is on track and what to push your GP for — or review your parent's Indian labs and medications and give you a clear, plain-language read on whether their diabetes is well controlled and what to ask their doctor in India. One family, two health systems, one specialist opinion that can speak to both.

What to do next — for you or for a parent

Three concrete steps:

1. Get the right tests ordered — against the right thresholds

Ask your GP for: HbA1c and fasting glucose, a full lipid panel with ApoB and a one-time Lp(a), urine albumin-to-creatinine ratio (uACR) and eGFR, blood pressure, a retinal screening referral, and waist circumference measured against South-Asian-specific cut-offs. Hand them the list — it's easier for everyone.

2. Get a written specialist opinion

An endocrinologist who works with this phenotype every day can tell you whether your targets are right for you, whether a cardio-renal-protective medication is warranted, and what a realistic remission plan might look like — for you, or for a parent whose reports you're holding.

3. Make the diet change stick, culturally

Small, sustainable adjustments to rice portions, grain choices, and meal composition beat a diet plan that ignores how your family actually eats. Ask specifically for advice that fits a South Asian kitchen.

How a specialist opinion from Ginie Health works

In plain terms: you upload your results — your Canadian labs, or your parent's Indian reports — and describe the history. Within 6 hours, for $45 CAD, you receive a written clinical opinion from an endocrinologist trained at PGIMER Chandigarh or AIIMS. The opinion explains what the numbers mean against the right thresholds, which additional tests to request, whether cardio-renal protection is warranted, and how to approach diet and possible remission. It doesn't replace your GP or your parent's doctor — it makes every one of those conversations sharper. If you'd rather talk it through, a live video consultation is available for $75 CAD. No referral required for either.